Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Calcitriol and metformin together are more effective for treating PCOS and lowering MCP-1 than metformin alone.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Intralesional cidofovir may be a viable alternative treatment for SCC.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

Calancardin B may help reduce inflammation in immune cells.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Small bowel lesions in Cronkhite-Canada syndrome persist despite steroid treatment.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Tofacitinib works better than methotrexate for severe alopecia in the short term.

Retinol may affect immune responses in people with frequent skin boils.